Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?

We sought to determine whether a polymorphism in the Interleukin 13 gene (IL13), 1112 C/T (rs1800925) predicts responsiveness to neoadjuvant chemoradiotherapy (neoCRT) and prognosis in Chinese Han patients with locally advanced rectal cancer (LARC). Pre-treatment biopsies of primary rectal lesion an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Lin, Yu, Xin, Zhang, Rong, Chang, Hui, Xi, Shaoyan, Xiao, Weiwei, Zeng, Zhifan, Zhang, Huizhong, Xu, Ruihua, Gao, Yuanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085143/
https://www.ncbi.nlm.nih.gov/pubmed/27167201
http://dx.doi.org/10.18632/oncotarget.9178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085143/
https://www.ncbi.nlm.nih.gov/pubmed/27167201
http://dx.doi.org/10.18632/oncotarget.9178

Ejemplares similares